This is a firm fixed-price purchase order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,484.12, is for the delivery of various pharmaceutical products such as Xolair, Trikafta, Keytruda, Botox, and Nucala to support the medical supply needs of military healthcare facilities. The contract has an ultimate completion date of December 27, 2024 and is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure this direct federal award. DMS Pharmaceutical Group also holds a $499,999,999 single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide.
Generated 3/13/25, 9:47 AM